Switzerland (CH)

Oligometastasis in breast cancer—current status and treatment options from a radiation oncology perspective (2022) Piroth MD, Krug D, Feyer P, Baumann R, Combs S, Duma MN, Dunst J, et al. Journal article, Review article Stent Optimization Using Optical Coherence Tomography and Its Prognostic Implications After Percutaneous Coronary Intervention (2022) Rai H, Harzer F, Otsuka T, Abdelwahed YS, Antuna P, Blachutzik F, Koppara T, et al. Journal article Comparative analysis of machine learning algorithms for multi-syndrome classification of neurodegenerative syndromes (2022) Lampe L, Niehaus S, Huppertz HJ, Merola A, Reinelt J, Mueller K, Anderl-Straub S, et al. Journal article Corrigendum to High-resolution large-scale onshore wind energy assessments: A review of potential definitions, methodologies and future research needs (Renewable Energy (2022) 182 (659–684), (S0960148121014841), (10.1016/j.renene.2021.10.027)) (2022) McKenna R, Pfenninger S, Heinrichs H, Schmidt J, Staffell I, Bauer C, Gruber K, et al. Journal article, Erratum Prediction of risk for bleeding, myocardial infarction and mortality after percutaneous coronary intervention in patients with acute coronary syndromes (2022) Ndrepepa G, Neumann FJ, Menichelli M, Richardt G, Cassese S, Xhepa E, Kufner S, et al. Journal article Dynamical scaling of correlations generated by short- and long-range dissipation (2022) Seetharam K, Lerose A, Fazio R, Marino J Journal article Etiology, 3-Month Functional Outcome and Recurrent Events in Non-Traumatic Intracerebral Hemorrhage (2022) Goeldlin MB, Mueller A, Siepen BM, Mueller M, Strambo D, Michel P, Schaerer M, et al. Journal article Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant treatment (2022) Marme F, Hanusch C, Furlanetto J, Morris P, Link T, Denkert C, Fasching P, et al. Conference contribution Intermediate biopsies during neoadjuvant chemotherapy for breast cancer to predict patient outcome (2022) Sinn BV, Untch M, Karn T, Van Mackelenbergh M, Huober J, Sychra K, Schmitt WD, et al. Conference contribution An Analysis of the Use Pattern of Hyperthermia (HT) in Combination with Radio(chemo)therapy or Chemotherapy in European HT Centers (2022) Ademaj A, Veltsista DP, Marder D, Haelg RA, Puric E, Brunner TB, Crezee H, et al. Conference contribution